National Institutes of Health Director Dr. Jay Bhattacharya attempted to reassure members of Congress on both sides of the aisle on Tuesday that his biomedical research agency is on the right track.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...

Kennedy Jr.’s first year in the Trump administration racked up win after win for the longtime anti-vaccine crusaders ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

On Feb. 19, “Ending HIV: The Journey to a Vaccine,” a new documentary, premiered at Boston’s Museum of Science. The premiere was preceded by a conversation with Dr. Anthony Fauci and Dr. Larry Corey, ...

The gutting of HIV drug programs isn't just bad policy; it threatens a repeat of history's deadliest mistake, writes John ...

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Mr Ghebreyesus said a new medicine approved in 2025 for HIV prevention, Lenacapavir, represents the most significant development in combating HIV since the first antiretroviral treatments were ...

How people with compromised immune systems respond to vaccines is an important area of immunological research. A study led by ...

Patients living with HIV in Havana reported receiving expired antiretroviral medications at state pharmacies as the health ...